Skip to content

Price / earnings at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
21.1×-1.1×
Herbalife logo
HerbalifeHLF
6.3×+3.2×
BellRing Brands logo
BellRing BrandsBRBR
11.9×-22.1×
Natural Grocers by Vitamin Cottage logo
Natural Grocers by Vitamin CottageNGVC
12.4×-10.0×
US Foods logo
US FoodsUSFD
30×+1.4×
Universal Corporation logo
Universal CorporationUVV
15.4×+4.7×

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0.0×
Current ratio2.5×+0.5×

Where this comes from

Calculated from USANA Health Sciences’s reported figures.

Based on the most recent quarter.

The official record: USANA Health Sciences’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's price / earnings?
USANA Health Sciences (USNA) reported price / earnings of 22.7× in Q3 2025.
How has USANA Health Sciences's price / earnings changed year-over-year?
USANA Health Sciences's price / earnings increased by 75.4% year-over-year, from 13× to 22.7×.
What is the long-term trend for USANA Health Sciences's price / earnings?
Over 4 years (2020 to 2024), USANA Health Sciences's price / earnings has grown at a 3.4% compound annual growth rate (CAGR), from 12.9× to 14.8×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.